sb 203580 has been researched along with s-ethyl glutathione in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (s-ethyl glutathione) | Trials (s-ethyl glutathione) | Recent Studies (post-2010) (s-ethyl glutathione) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 189 | 0 | 41 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dobashi, K; Endou, K; Hamuro, J; Ishizuka, T; Mori, M; Murata, Y; Nakazawa, T; Utsugi, M | 1 |
1 other study(ies) available for sb 203580 and s-ethyl glutathione
Article | Year |
---|---|
c-Jun N-terminal kinase negatively regulates lipopolysaccharide-induced IL-12 production in human macrophages: role of mitogen-activated protein kinase in glutathione redox regulation of IL-12 production.
Topics: Anthracenes; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Glutathione; Humans; Imidazoles; Interleukin-12; Interleukin-12 Subunit p40; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Macrophages; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Mitogen-Activated Protein Kinases; Oligonucleotides, Antisense; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Protein Subunits; Pyridines; RNA, Messenger; Tumor Cells, Cultured; Up-Regulation | 2003 |